TreeFrog Therapeutics raises 7.1 mln euros

TreeFrog Therapeutics said May 13 that it raised 7.1 million euros ($7.8 million) in a series A round led by XAnge (Siparex Group). Galia Gestion, a new investor, along with historical investors from the earlier seed funding round, Irdi Soridec, Aquiti Gestion and SATT Aquitaine, participated. TreeFrog, of Bordeaux, France, is a stem cell company.

North AmericaUSBriefs